An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.


NEWS | July 18, 2023

JPEO-CBRND Awards $39.8 Million Contract to Kaléo, Inc. for Next Generation Reconstitution Autoinjector Device – Atropine (RAD-A)

By Press Release

Frederick, MD – On July 14, 2023, the Department of Defense (DOD) awarded $39.8 million to Kaléo, Inc. to develop the Reconstitution Autoinjector Device – Atropine (RAD-A).

The RAD-A is a novel wet/dry autoinjector device that will reconstitute dry atropine upon activation, critical in the treatment of nerve agent exposure. Successful completion of the development phase will allow Kaléo to achieve U.S. Food and Drug Administration approval and production capacity of RAD-A.

“The innovative approach led by a joint government and U.S.-based industry team enables the shelf-life of the autoinjector to be extended, and ultimately reduces the sustainment burden for the Joint Force,” said COL Matthew G. Clark, Joint Project Manager for the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical). “Additionally, the RAD-A will serve as a platform technology for various medical countermeasures in defense of our warfighters.”

This effort was led by the DOD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the U.S. Army Contracting Command – Aberdeen Proving Ground, Edgewood Division.

About the JPEO-CBRND:
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) mission is to provide an integrated layered chemical, biological, radiological, and nuclear defense capabilities to the Joint Force across combined Joint All-Domain Operations. JPEO-CBRND’s goal is to enable the Joint Force to fight and win unencumbered by a CBRN environment. To learn more about JPEO-CBRND, visit:, or follow JPEO-CBRND on social media @JPEOCBRND.


Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.  



JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.